PAhR Therapeutics

Drug Discovery · Boston, MA · Founded 2025 · Privately Held (backing)

Operator of a clinical-stage biotechnology company intended to develop novel therapies for pulmonary arterial hypertension through innovative molecular mechanisms. PAhR Therapeutics is based in Boston, MA and was founded in 2025. It was valued at $25 million at its seed round in Jul 2025, the last priced event on record. It has raised $14 million across 1 recorded round; the latest was a $14 million seed round in Jul 2025.

PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jul 2025
Total raised
$14.0M
Last round
Seed Round
Jul 2025
How much has PAhR Therapeutics raised?
$14.0Macross 1 recorded rounds · Jul 2025 – Jul 2025

Most recently, PAhR Therapeutics raised $14.0M in its Seed Round (Jul 2025).

Free account
More of PAhR Therapeutics with a free account
  • ·Watch PAhR Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

PAhR Therapeutics round by round

1 rounds
Jul 2025Seed Round$14.0M▮
+ 1 more investors · free account

How much has PAhR Therapeutics raised?

PAhR Therapeutics has raised $14 million across 1 recorded round since 2025. The largest was a $14 million seed round in Jul 2025.

PAhR Therapeutics has filed 1 Form D with the SEC, most recently in Jul 2025 ($4.7 million sold to 4 investors).

PAhR Therapeutics investors

3 investors are on record for PAhR Therapeutics, including RA Capital Management, The University of Tokyo Edge Capital and AN Ventures. The seed round in Jul 2025 drew 2 investors.

For fundraisers
Raising for a company like PAhR Therapeutics?

3 investors have backed PAhR Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 3 investors →

Frequently asked about PAhR Therapeutics

How much has PAhR Therapeutics raised?
PAhR Therapeutics has raised $14.0M in total across 1 recorded funding rounds.
When was PAhR Therapeutics's last funding round?
PAhR Therapeutics's most recent recorded round was Seed Round in Jul 2025, raising $14.0M.